The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | How genomic testing is used in the prognostication and diagnosis of patients with CLL
William Wierda, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the importance of genomic testing in chronic lymphocytic leukemia (CLL), and further highlights various methods used in the prognosis and diagnosis of patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
